Introduction Pulmonary oligometastases have conventionally been managed with surgery
and/or systemic therapy. However, given concerns about the high cost of systemic therapy …

Local treatment for pulmonary oligometastases (one to five lesions) using metastasectomy
or stereotactic ablative radiotherapy (SABR) was investigated in a cohort that received …

Introduction Hypofractionated stereotactic body radiotherapy (SBRT) is an emerging
noninvasive technique for the treatment of oligometastatic cancer. The use of small numbers …

An increasing body of experience suggests that oligometastasis represents a minimal
metastatic state with the potential for cure or prolonged survival in selected patients treated …

Aim: This study was performed to confirm the superior overall survival (OS) after pulmonary
oligo-recurrence compared to pulmonary sync-oligometastases in a large nationwide study …

Background: Stereotactic body radiotherapy (SBRT) for pulmonary oligometastatic disease
achieves excellent treatment outcomes in terms of local control and toxicity. Patients treated …

Aim: The current study investigated outcomes and prognostic factors of pulmonary
oligometastases at two Institutions. Patients and Methods: SBRT (stereotactic body …

Background and purpose Stereotactic ablative radiotherapy (SABR; or stereotactic body
radiotherapy, SBRT) emerges as treatment option for pulmonary oligometastatic disease …

Background Oligometastases can be divided into sync-oligometastases and oligo-
recurrence. The difference is whether the primary site is uncontrolled or controlled. The goal …

Purpose To assess the clinical results in terms of local control, toxicity, failure pattern and
toxicity of SBRT in oligometastatic patients with inoperable lung metastases. Methods Forty …